Global Human Prothrombin Complex Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Human Prothrombin Complex Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

According to APO Research, The global Human Prothrombin Complex market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.

This report presents an overview of global market for Human Prothrombin Complex, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Human Prothrombin Complex, also provides the sales of main regions and countries. Of the upcoming market potential for Human Prothrombin Complex, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Prothrombin Complex sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Prothrombin Complex market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Prothrombin Complex sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Takeda, CSL, Grifols, Octapharma, Hualan Biological and Meheco Xinxing Pharma, etc.
Human Prothrombin Complex segment by Company

Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Human Prothrombin Complex segment by Type

500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Human Prothrombin Complex segment by Application

Hemophilia B
Vitamin K Deficiency
Others
Human Prothrombin Complex segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Human Prothrombin Complex status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Human Prothrombin Complex market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Human Prothrombin Complex significant trends, drivers, influence factors in global and regions.
6. To analyze Human Prothrombin Complex competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Prothrombin Complex market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Prothrombin Complex industry.
Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Human Prothrombin Complex in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Human Prothrombin Complex Sales Value (2019-2030)
1.2.2 Global Human Prothrombin Complex Sales Volume (2019-2030)
1.2.3 Global Human Prothrombin Complex Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Human Prothrombin Complex Market Dynamics
2.1 Human Prothrombin Complex Industry Trends
2.2 Human Prothrombin Complex Industry Drivers
2.3 Human Prothrombin Complex Industry Opportunities and Challenges
2.4 Human Prothrombin Complex Industry Restraints
3 Human Prothrombin Complex Market by Company
3.1 Global Human Prothrombin Complex Company Revenue Ranking in 2023
3.2 Global Human Prothrombin Complex Revenue by Company (2019-2024)
3.3 Global Human Prothrombin Complex Sales Volume by Company (2019-2024)
3.4 Global Human Prothrombin Complex Average Price by Company (2019-2024)
3.5 Global Human Prothrombin Complex Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Human Prothrombin Complex Company Manufacturing Base & Headquarters
3.7 Global Human Prothrombin Complex Company, Product Type & Application
3.8 Global Human Prothrombin Complex Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Human Prothrombin Complex Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Human Prothrombin Complex Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Human Prothrombin Complex Market by Type
4.1 Human Prothrombin Complex Type Introduction
4.1.1 500 IU/Vial
4.1.2 600 IU/Vial
4.1.3 1000 IU/Vial
4.1.4 Others
4.2 Global Human Prothrombin Complex Sales Volume by Type
4.2.1 Global Human Prothrombin Complex Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Human Prothrombin Complex Sales Volume by Type (2019-2030)
4.2.3 Global Human Prothrombin Complex Sales Volume Share by Type (2019-2030)
4.3 Global Human Prothrombin Complex Sales Value by Type
4.3.1 Global Human Prothrombin Complex Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Human Prothrombin Complex Sales Value by Type (2019-2030)
4.3.3 Global Human Prothrombin Complex Sales Value Share by Type (2019-2030)
5 Human Prothrombin Complex Market by Application
5.1 Human Prothrombin Complex Application Introduction
5.1.1 Hemophilia B
5.1.2 Vitamin K Deficiency
5.1.3 Others
5.2 Global Human Prothrombin Complex Sales Volume by Application
5.2.1 Global Human Prothrombin Complex Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Human Prothrombin Complex Sales Volume by Application (2019-2030)
5.2.3 Global Human Prothrombin Complex Sales Volume Share by Application (2019-2030)
5.3 Global Human Prothrombin Complex Sales Value by Application
5.3.1 Global Human Prothrombin Complex Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Human Prothrombin Complex Sales Value by Application (2019-2030)
5.3.3 Global Human Prothrombin Complex Sales Value Share by Application (2019-2030)
6 Human Prothrombin Complex Market by Region
6.1 Global Human Prothrombin Complex Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Human Prothrombin Complex Sales by Region (2019-2030)
6.2.1 Global Human Prothrombin Complex Sales by Region: 2019-2024
6.2.2 Global Human Prothrombin Complex Sales by Region (2025-2030)
6.3 Global Human Prothrombin Complex Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Human Prothrombin Complex Sales Value by Region (2019-2030)
6.4.1 Global Human Prothrombin Complex Sales Value by Region: 2019-2024
6.4.2 Global Human Prothrombin Complex Sales Value by Region (2025-2030)
6.5 Global Human Prothrombin Complex Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Human Prothrombin Complex Sales Value (2019-2030)
6.6.2 North America Human Prothrombin Complex Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Human Prothrombin Complex Sales Value (2019-2030)
6.7.2 Europe Human Prothrombin Complex Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Human Prothrombin Complex Sales Value (2019-2030)
6.8.2 Asia-Pacific Human Prothrombin Complex Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Human Prothrombin Complex Sales Value (2019-2030)
6.9.2 Latin America Human Prothrombin Complex Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Human Prothrombin Complex Sales Value (2019-2030)
6.10.2 Middle East & Africa Human Prothrombin Complex Sales Value Share by Country, 2023 VS 2030
7 Human Prothrombin Complex Market by Country
7.1 Global Human Prothrombin Complex Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Human Prothrombin Complex Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Human Prothrombin Complex Sales by Country (2019-2030)
7.3.1 Global Human Prothrombin Complex Sales by Country (2019-2024)
7.3.2 Global Human Prothrombin Complex Sales by Country (2025-2030)
7.4 Global Human Prothrombin Complex Sales Value by Country (2019-2030)
7.4.1 Global Human Prothrombin Complex Sales Value by Country (2019-2024)
7.4.2 Global Human Prothrombin Complex Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.5.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.6.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.7.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.8.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.9.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.10.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.11.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.12.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.13.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.14.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.15.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.16.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.17.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.18.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.19.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.20.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.21.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.22.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Human Prothrombin Complex Sales Value Growth Rate (2019-2030)
7.23.2 Global Human Prothrombin Complex Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Human Prothrombin Complex Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Takeda
8.1.1 Takeda Comapny Information
8.1.2 Takeda Business Overview
8.1.3 Takeda Human Prothrombin Complex Sales, Value and Gross Margin (2019-2024)
8.1.4 Takeda Human Prothrombin Complex Product Portfolio
8.1.5 Takeda Recent Developments
8.2 CSL
8.2.1 CSL Comapny Information
8.2.2 CSL Business Overview
8.2.3 CSL Human Prothrombin Complex Sales, Value and Gross Margin (2019-2024)
8.2.4 CSL Human Prothrombin Complex Product Portfolio
8.2.5 CSL Recent Developments
8.3 Grifols
8.3.1 Grifols Comapny Information
8.3.2 Grifols Business Overview
8.3.3 Grifols Human Prothrombin Complex Sales, Value and Gross Margin (2019-2024)
8.3.4 Grifols Human Prothrombin Complex Product Portfolio
8.3.5 Grifols Recent Developments
8.4 Octapharma
8.4.1 Octapharma Comapny Information
8.4.2 Octapharma Business Overview
8.4.3 Octapharma Human Prothrombin Complex Sales, Value and Gross Margin (2019-2024)
8.4.4 Octapharma Human Prothrombin Complex Product Portfolio
8.4.5 Octapharma Recent Developments
8.5 Hualan Biological
8.5.1 Hualan Biological Comapny Information
8.5.2 Hualan Biological Business Overview
8.5.3 Hualan Biological Human Prothrombin Complex Sales, Value and Gross Margin (2019-2024)
8.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
8.5.5 Hualan Biological Recent Developments
8.6 Meheco Xinxing Pharma
8.6.1 Meheco Xinxing Pharma Comapny Information
8.6.2 Meheco Xinxing Pharma Business Overview
8.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Value and Gross Margin (2019-2024)
8.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
8.6.5 Meheco Xinxing Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Human Prothrombin Complex Value Chain Analysis
9.1.1 Human Prothrombin Complex Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Human Prothrombin Complex Sales Mode & Process
9.2 Human Prothrombin Complex Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Human Prothrombin Complex Distributors
9.2.3 Human Prothrombin Complex Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings